Publicação
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma
| dc.contributor.author | Quinet, Grégoire | |
| dc.contributor.author | Xolalpa, Wendy | |
| dc.contributor.author | Reyes-Garau, Diana | |
| dc.contributor.author | Profitós-Pelejà, Núria | |
| dc.contributor.author | Azkargorta, Mikel | |
| dc.contributor.author | Ceccato, Laurie | |
| dc.contributor.author | Gonzalez-Santamarta, Maria | |
| dc.contributor.author | Marsal, Maria | |
| dc.contributor.author | Andilla, Jordi | |
| dc.contributor.author | Aillet, Fabienne | |
| dc.contributor.author | Bosch, Francesc | |
| dc.contributor.author | Elortza, Felix | |
| dc.contributor.author | Loza-Alvarez, Pablo | |
| dc.contributor.author | Sola, Brigitte | |
| dc.contributor.author | Coux, Olivier | |
| dc.contributor.author | Matthiesen, Rune | |
| dc.contributor.author | Matthiesen, Rune | |
| dc.contributor.author | Roué, Gaël | |
| dc.contributor.author | Rodriguez, Manuel S. | |
| dc.contributor.institution | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) | |
| dc.contributor.institution | Centro de Estudos de Doenças Crónicas (CEDOC) | |
| dc.contributor.pbl | MDPI - Multidisciplinary Digital Publishing Institute | |
| dc.date.accessioned | 2022-03-14T23:23:02Z | |
| dc.date.available | 2022-03-14T23:23:02Z | |
| dc.date.issued | 2022-02-01 | |
| dc.description | Funding Information: Funding: This work was supported at early stages by Spanish MINECO, CTQ2011–27874 grant. M.G.-S. is a fellow of the UbiCODE project funded by the EU’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 765445. | |
| dc.description.abstract | Protein ubiquitylation coordinates crucial cellular events in physiological and pathological conditions. A comparative analysis of the ubiquitin proteome from bortezomib (BTZ)-sensitive and BTZ-resistant mantle cell lymphoma (MCL) revealed an enrichment of the autophagy-lysosome system (ALS) in BTZ-resistant cells. Pharmacological inhibition of autophagy at the level of lysosome-fusion revealed a constitutive activation of proteaphagy and accumulation of proteasome subunits within autophagosomes in different MCL cell lines with acquired or natural resistance to BTZ. Inhibition of the autophagy receptor p62/SQSTM1 upon verteporfin (VTP) treatment disrupted proteaphagosome assembly, reduced co-localization of proteasome subunits with autophagy markers and negatively impacted proteasome activity. Finally, the silencing or pharmacological inhibition of p62 restored the apoptosis threshold at physiological levels in BTZ-resistant cells both in vitro and in vivo. In total, these results demonstrate for the first time a proteolytic switch from the ubiquitin-proteasome system (UPS) to ALS in B-cell lymphoma refractory to proteasome inhibition, pointing out a crucial role for proteaphagy in this phenomenon and paving the way for the design of alternative therapeutic venues in treatment-resistant tumors. | en |
| dc.description.version | publishersversion | |
| dc.description.version | published | |
| dc.format.extent | 26047138 | |
| dc.identifier.doi | 10.3390/cancers14040923 | |
| dc.identifier.issn | 2072-6694 | |
| dc.identifier.other | PURE: 42051362 | |
| dc.identifier.other | PURE UUID: 2158af6c-d910-478c-a692-040f73948d4c | |
| dc.identifier.other | Scopus: 85124958813 | |
| dc.identifier.other | WOS: 000763741100001 | |
| dc.identifier.uri | http://hdl.handle.net/10362/134490 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/85124958813 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.subject | Apoptosis | |
| dc.subject | Autophagy | |
| dc.subject | Proteasome inhibitor | |
| dc.subject | TUBEs | |
| dc.subject | Ubiquitin proteome | |
| dc.subject | Verteporfin | |
| dc.subject | Oncology | |
| dc.subject | Cancer Research | |
| dc.subject | SDG 3 - Good Health and Well-being | |
| dc.title | Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma | en |
| dc.type | journal article | |
| degois.publication.issue | 4 | |
| degois.publication.title | Cancers | |
| degois.publication.volume | 14 | |
| dspace.entity.type | Publication | |
| person.familyName | Matthiesen | |
| person.givenName | Rune | |
| person.identifier | 1319342 | |
| person.identifier.ciencia-id | BB1A-A606-EE77 | |
| person.identifier.orcid | 0000-0002-6353-2616 | |
| person.identifier.scopus-author-id | 9741897800 | |
| rcaap.rights | openAccess | |
| relation.isAuthorOfPublication | 67181d3c-b83e-4151-9a74-0ea14aeb7f05 | |
| relation.isAuthorOfPublication.latestForDiscovery | 67181d3c-b83e-4151-9a74-0ea14aeb7f05 |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- cancers_14_00923_1_.pdf
- Tamanho:
- 24.84 MB
- Formato:
- Adobe Portable Document Format
